Invention Grant
- Patent Title: Prodrugs of CGRP antagonists
-
Application No.: US17283049Application Date: 2019-10-10
-
Publication No.: US12030868B2Publication Date: 2024-07-09
- Inventor: Charles M. Conway , Gene M. Dubowchik , Jeffrey Claude Pelletier , Allen B. Reitz
- Applicant: Pfizer Ireland Pharmaceuticals
- Applicant Address: IE County Cork
- Assignee: Pfizer Ireland Pharmaceuticals
- Current Assignee: Pfizer Ireland Pharmaceuticals
- Current Assignee Address: IE Ringaskiddy
- Agent Jessica Zimberlin Eastman
- International Application: PCT/US2019/055525 2019.10.10
- International Announcement: WO2020/077038A 2020.04.16
- Date entered country: 2021-04-06
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D498/22
Abstract:
Disclosed are prodrugs of CGRP antagonists, methods of treating CGRP related disorders, e.g., migraine, by administering to a patient in need thereof the prodrugs, pharmaceutical compositions comprising prodrugs and kits including the pharmaceutical compositions and instructions for use.
Public/Granted literature
- US20210395223A1 PRODRUGS OF CGRP ANTAGONISTS Public/Granted day:2021-12-23
Information query
